Recurrent Diabetic Macular Edema: What to Do
Diabetic macular edema (DME) is a leading cause of blindness in the working population. Herein, we report the case of a patient with recurrent DME for about 6 years, uncontrolled by several medical and surgical treatments, that was successfully treated with a single sustained-release fluocinolone ac...
Main Authors: | Rita Santos Gonçalves, Carla Teixeira, Pedro Coelho |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-09-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/480119 |
Similar Items
-
Intravitreal Ranibizumab for Diabetic Macular Edema Patients with Good Baseline Visual Acuity: A Real-Life Study
by: Abdullah Ozkaya, et al.
Published: (2017-10-01) -
Real-world outcomes of two-year Conbercept therapy for diabetic macular edema
by: Yong Cheng, et al.
Published: (2021-03-01) -
Lipemia Retinalis, Macular Edema, and Vision Loss in a Diabetic Patient with a History of Type IV Hypertriglyceridemia and Pancreatitis
by: John W. Hinkle, et al.
Published: (2018-10-01) -
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
by: Chang Ki Yoon, et al.
Published: (2021-01-01) -
Intravitreal injection of triamcinolone acetonide for diabetic macular edema: Principles and practice
by: Vedantham Vasumathy, et al.
Published: (2006-01-01)